1985
DOI: 10.1007/978-3-642-69518-6_14
|View full text |Cite
|
Sign up to set email alerts
|

Barbituric Acid Derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

1986
1986
2000
2000

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 65 publications
0
3
0
Order By: Relevance
“…Because the hypnotic properties of barbiturates are related to lipid solubility (reviewed in Gallagher & Freer, 1985), binding sites for anaesthetics may be located in a lipophilic pocket of the receptor, and the transmembrane domains may possibly contain residues that bind pentobarbital. However, in the nicotinic acetylcholine receptor, these regions contain residues which can dramatically affect gating mechanisms, as well (reviewed in Karlin & Akabas, 1995).…”
mentioning
confidence: 99%
“…Because the hypnotic properties of barbiturates are related to lipid solubility (reviewed in Gallagher & Freer, 1985), binding sites for anaesthetics may be located in a lipophilic pocket of the receptor, and the transmembrane domains may possibly contain residues that bind pentobarbital. However, in the nicotinic acetylcholine receptor, these regions contain residues which can dramatically affect gating mechanisms, as well (reviewed in Karlin & Akabas, 1995).…”
mentioning
confidence: 99%
“…No previous systematic studies have dealt with the effect of anticonvulsant drugs on 3SS-TBPS binding. According to this study, phenobarbital was the only drug that significantly affected 35S-TBPS binding after chronic administration of the drug at the dose known to protect rats from seizures (Gallagher & Freer 1985). Phenobarbital decreased the number of receptor sites in cortical membranes.…”
Section: Discussionmentioning
confidence: 78%
“…The drug doses used in the ex vivo experiment were selected according to the previous data, where such doses were shown to protect rats from several types of seizures (Gallagher & Freer 1985;Jones & Wimbish 1985;Teschendorf & Kretzschmar 1985;Caccia & Garattini 1985). Following daily administration the levels of drugs in rat plasma were found to be of the same magnitude as the known therapeutic concentrations of anticonvulsants in human plasma (Tokola & Neuvonen 1983).…”
Section: Discussionmentioning
confidence: 99%